Enanta Pharmaceuticals | ENTA - Ebitda





Ebitda Perubahan Tanggal
AbbVie USD 6.91B 3.22B 2026-06
Amgen USD 5.8B 1.25B 2026-09
Anika Therapeutics USD 4.54M 3.67M 2025-12
Arrowhead Research USD -147.68M 40.33M 2026-06
AstraZeneca USD 7.46B 2.3B 2026-09
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
Biogen USD 450.8M 198.9M 2026-06
Bristol-Myers Squibb USD 3.48B 1.6B 2026-09
Gilead Sciences USD -9.31B 12.82B 2026-06
GlaxoSmithKline GBP 3.51B 734M 2026-06
Halozyme Therapeutics USD 336.16M 7.34M 2026-09
Heron Therapeutics USD -3.88M 5.63M 2024-09
Immunic USD -22.78M 753K 2024-06
Incyte USD 778.57M 410.6M 2026-06
Insmed USD -80.97M 93.7M 2026-09
Ionis Pharmaceuticals USD -64.53M 135.49M 2026-03
J&J USD 8.99B 721M 2026-06
Karyopharm Therapeutics USD -26.2M 1.83M 2024-09
Ligand Pharmaceuticals USD 74.27M 88.56M 2026-06
Merck USD 1.42B 2.97B 2026-06
Neurocrine Biosciences USD 375.3M 185.4M 2026-09
Novartis USD 8.62B 2.14B 2026-09
Novavax USD 19.36M 190.79M 2025-12
Pfizer USD 6.36B 350M 2026-09
PTC Therapeutics USD 161.9M 99.92M 2026-06
Roche Holding CHF 13.43B 744M 2026-06
Sarepta Therapeutics USD -3.14M 33.31M 2026-09
Vertex Pharmaceuticals USD 1.33B 130.5M 2026-06